Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026, Mar 2026 and Jun 2026.
- Largest single sale: $13.3M (412,032 shares) of Teva Pharmaceutical Industries Ltd on Mar 3, 2026. Filing
- Last sale before this period: Mar 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | President and CEO | Feb 17, 2023 | Jun 8, 2026 |
| Mettler Toledo (MTD) | Former Director | Nov 7, 2016 | Nov 14, 2024 |
Also a director at
Mettler Toledo (MTD) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 5, 2026, Teva Pharmaceutical Industries Ltd: sold 6,153 shares for $211K, under a disclosed plan; 13,043 shares vested. 1 filing: 1
- Mar 5, 2026, Teva Pharmaceutical Industries Ltd: sold 20,025 shares for $634K, under a disclosed plan; 42,452 shares vested. 1 filing: 1
- Mar 4, 2026, Teva Pharmaceutical Industries Ltd: sold 23,393 shares for $759K, under a disclosed plan; 50,223 shares vested. 1 filing: 1
- Mar 3, 2026, Teva Pharmaceutical Industries Ltd: sold 442,935 shares for $14.3M, under a disclosed plan; 958,546 shares vested. 1 filing: 1
- Feb 15, 2026, Teva Pharmaceutical Industries Ltd: sold 447,778 shares for $15.3M, under a disclosed plan; 781,766 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.